Results 141 to 150 of about 21,847 (205)

The Immunologic Paradox of BTK Inhibitors in Chronic Lymphocytic Leukemia: Selectivity, Hypogammaglobulinemia, and Infection Risk. [PDF]

Cancers (Basel)
Andreescu M, Tudorache SI, Moldovan CA, Moldovan AD, Cochior D, Popov V, Andreescu B, Ionescu D, Padurariu-Covit MD.   +8 more
europepmc   +1 more source

The efficacy, safety, and rationale of orelabrutinib combined with obinutuzumab (O2) as a first-line systemic treatment for marginal zone lymphoma. [PDF]

Blood Cancer J
Xu J, Li J, Ren Y, Cheng L, Cheng Z, Zhuang J, Ke Y, Gu S, Zhang Y, Chen F, Gao R, Li P, Xiong Y, Liu P.   +13 more
europepmc   +1 more source

Clinical and genetic characterization of X-linked agammaglobulinemia in a Colombian cohort. [PDF]

World Allergy Organ J
Olaya Hernández M, Triviño Arias J, Arias Valderrama O, Cabrera Guarín V, Patiño JA, Pachajoa HM, Valencia DM, Franco AA, Castaño Jaramillo LM, Vélez Tirado N, Zea-Vera AF, Ortega-López MC, Olmos-Olmos C, Arévalo-Montenegro Y, Rincón-Arenas L, Franco JL, Orrego JC, Vásquez E, Obando-Gil C, Moribe I, Valderrama ML, Gómez-Parada C, Álvarez M, Arias AF, Pérez PM, Correa Jiménez O.   +25 more
europepmc   +1 more source

Bruton's tyrosine kinase inhibitor BTKi-2 inhibits mpox virus and vaccinia virus infection. [PDF]

Virol Sin
Yang C, Zhao R, Huo S, Zhang Y, Feng J, Gong M, Zhu L, Zhang C, Zhang L, Xue J, Zhang R, Wang Q, Ding Q.   +12 more
europepmc   +1 more source

BTKi orelabrutinib improved the outcome of newly-diagnosed PCNS-LBCL by alleviating MyD88^L265P-induced PIM1 stability. [PDF]

J Hematol Oncol
Yuan Y, Dai B, Zhong H, Zheng J, Fan Z, Chen D, Wang Q, Wu H, Li Y, Zhu P, Ding T, Wang S, Wu K, Zhang Y, Wang Z, Feng R, Zhu F, Zheng K, Qin Z, Yang B, Chen H, Lin X, Yao Y, Zhuang D, Shi Z, Mao Y, Chen T.   +26 more
europepmc   +1 more source

Repurposing Tyrosine Kinase Inhibitors for Sickle Cell Disease: Focus on Band 3 Phosphorylation. [PDF]

Biomedicines
Gupta R, Mishra N, Madkaikar M, Singh RK.   +3 more
europepmc   +1 more source

Atypical X-linked agammaglobulinemia diagnosed in adulthood with arthritis caused by a hypomorphic BTK splice-site variant: a case report and literature review. [PDF]

Front Immunol
Takayama A, Meguro K, Yokota M, Sugiyama T, Kurihara S, Hiraguri M, Kanegane H, Nakajima H.   +7 more
europepmc   +1 more source

Covalent Bruton's tyrosine kinase inhibitor HZ-A-018 in patients with relapsed or refractory B cell malignancies: A multicenter phase I study. [PDF]

iScience
Wu G, Wei J, Yang H, Fan L, Yu S, Zhang J, Lin M, Zhou H, Xu N, Hu M, Zhou X, Jin J, Qian W, Shentu J.   +13 more
europepmc   +1 more source

Integrating Network Pharmacology and Experimental Validation Reveals EGFR/PI3K/Akt Axis Mediates Ibrutinib-Induced Cardiotoxicity. [PDF]

Dose Response
Guan Y, Mei J, He Y, Lu M, Cheng B, Zhang X.   +5 more
europepmc   +1 more source